# TmCD19-IL18 in CD19+ Cancers

> **NCT05989204** · PHASE1 · RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 24 (estimated)

## Conditions studied

- Non Hodgkin Lymphoma

## Interventions

- **BIOLOGICAL:** TmCD19-IL18

## Key facts

- **NCT ID:** NCT05989204
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-13
- **Primary completion:** 2026-10-01
- **Final completion:** 2041-10-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05989204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05989204, "TmCD19-IL18 in CD19+ Cancers". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT05989204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*